Clinical Trials Logo

Clinical Trial Summary

Background. Cardiopulmonary bypass in on-pump cardiac surgery (OPCS) can have harmful effects by ischemia-reperfusion. No data about the effects of remote ischemic postconditioning (RIP) in hypoxia-inducible factor-1 alpha (HIF-1α) plasma level after OPCS. The aim of this study is evaluate the effects of RIP on postoperative HIF-1α plasma levels, cardiac markers and arterial oxygenation of patients after OPCS.

Methods. Randomised controlled study in 70 patients undergoing OPCS: 35 patients receive RIP (RIP group) and 35 patients not (control group). Patients receive RIP on upper limb: 5 min of ischemia followed by 5 min of reperfusion (3 cycles) immediately after leaving on-pump. The primary outcome was to know the HIF-1α plasma levels after surgery in both groups: before starting surgery (T0) and after CPB period at 2 h (T1), 8 h (T2), 24 h (T3), 36 h (T4), 48 h (T5). Secondary outcomes included to measure the cardiac markers levels (Troponin T, CK-MB, CPK), arterial oxygenation (PaO2/FiO2) and others.


Clinical Trial Description

Cardiac surgery with cardiopulmonary bypass (CPB) is associated with ischemia-reperfusion (I-R) injury. Acute myocardial injury after cardiac surgery is associated with increased mortality and morbidity. In 1993, reported that brief circumflex artery occlusion reduces myocardial infarct size induced by a definitive occlusion of the left anterior descending artery, a phenomenon which has been named remote ischemic preconditioning (RIPC). This approach confers resistance to subsequent ischemic episodes in remote organs, possibly by transferring protective mediators through humoral, neuronal, and systemic mechanisms, however the mechanisms involved are not yet fully known. A recent study has found that cardioprotection induced by RIPC the mitochondria appear to be an important subcellular effector organelle. It has been reported that RIPC could be a potential protective approach for perioperative complications. Therefore, the effects on myocardial injury and clinical outcome in patients undergoing on-pump cardiac surgery (OPCS) are inconclusive. In the present study, we conducted a randomized clinical trial on patients undergoing OPCS by application of remote ischemic postconditioning (RIP), an alternative to remote ischemic preconditioning. RIP can be applied in different clinical situations, medical or surgical, when reperfusion is initiated and associated to acidosis, nitric oxide formation, mitochondrial permeability transition pore inhibition and reactive oxygen species generation. In the present study we have opted for remote postconditioning because we speculate a possible losses of plasmatic effectors during CPB procedures using polyvinylchloride (PVC) tubing. Since, when blood is exposed to the PVC surface the plasma proteins may be adsorbed. Also to minimize the bleeding or hemodilution effects on the potential protective plasmatic effectors levels during CPB.

Tissue exposure to low O2 concentration starts a hypoxic response of the hypoxia-inducible factor 1 (HIF-1), a transcription factor heterodimer, consisting of an O2 regulated HIF-1α subunit and a constitutively expressed HIF-1β subunit that binds to the consensus sequence 5'-RCGTG-3', which is present near HIF-1-regulated genes. HIF-1α protein stability is upregulated in response to hypoxia. HIF-1α protein stability is negatively regulated by O2-dependent prolyl hydroxylation and is degraded under normoxia by prolyl hydroxylase. HIF-1α plays a critical role in the mammalian cells activating genes associate with angiogenesis, ischemia, energy metabolism and cell cycle.

The aim of this study carried out in patients undergoing OPCS was the determination of the time course of HIF-1α plasma levels in response to RIP and the possible correlation between aortic cross-clamping time and HIF-1α plasma levels in both groups. HIF-1α role in remote ischemic conditioning (pre or post) is very little known. Therefore, we tested the hypothesis that RIP induces cardiac protection after OPCS and that this is associated to an increase of HIF-1α plasma levels. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04284592
Study type Interventional
Source INCLIVA
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date October 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05327348 - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery Phase 3
Completed NCT00184912 - The Effect of Caffeine on Ischemic Preconditioning N/A
Recruiting NCT05585255 - Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
Completed NCT05598177 - Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass Phase 4
Withdrawn NCT00441714 - Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise N/A
Completed NCT00248040 - Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation Phase 2
Completed NCT01486212 - Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers N/A
Recruiting NCT06097702 - A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants Phase 1
Completed NCT00224406 - Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation Phase 2
Completed NCT01073202 - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation N/A
Active, not recruiting NCT05246618 - FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation Phase 1/Phase 2
Completed NCT02118753 - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium N/A
Completed NCT01739088 - Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery N/A
Completed NCT01040013 - Gut Oxygenation and Laparoscopy Phase 2
Suspended NCT00184847 - Adenosine Receptors Influence Ischemia-Reperfusion Injury N/A
Completed NCT01172171 - The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction Phase 2
Completed NCT00457405 - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury? Phase 4
Completed NCT00184821 - Ischemic Injury and Ischemic Preconditioning in Diabetes N/A
Not yet recruiting NCT00691613 - Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model N/A
Completed NCT03818126 - The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement N/A